Partial
Partially Aligned
Patient Risk:
Moderate
Summary
Several statements align with the provided label excerpts (indication, nasal-only use, single-use, second-dose timing). However, multiple expiration-related claims are not supported by the supplied prescribing information excerpts, including whether to consider the product unusable after expiration and reliability/potency statements.
Category Scores
Accurate Statements
Neffy refers to neffy (epinephrine) nasal spray.
Neffy description indicates Neffy is epinephrine nasal spray (11 DESCRIPTION).
Neffy is an emergency medicine.
Indication is emergency treatment of type I allergic reactions including anaphylaxis (1 INDICATIONS AND USAGE).
Do not rely on expired neffy stock for treatment of anaphylaxis.
The provided label excerpts do not address expiration; therefore this is not supported (see unsupportedStatements).
If multiple units are available, track dates per device because they may not expire on the same day.
Not supported by provided label excerpts.
The expiration date should be checked on the printed expiration date on the outer carton and the container label.
Not supported by provided label excerpts.
Unsupported Statements
Like other medications, neffy has an expiration date printed on the package or label.
Expiration-date statements are not present in the provided FDA label excerpts.
After the expiration date, the manufacturer cannot guarantee the product will deliver the intended amount of medication.
No expiration/quality/guarantee language appears in the provided excerpts.
After the expiration date, neffy should be considered expired and not used.
No label excerpt provided addresses use/non-use after expiration.
With expired epinephrine products, the main issue is reliability (how well they work).
No label excerpt provided addresses issues with expired epinephrine products.
Expiration can affect potency of epinephrine products.
No label excerpt provided addresses potency changes with expiration.
Do not rely on expired neffy stock for treatment of anaphylaxis.
While the label supports emergency treatment, the provided excerpts do not address expired product use.
If unexpired epinephrine is not available, follow the instructions given by the clinician and emergency plan.
No label excerpt provided addresses what to do when unexpired product is unavailable.
Do not delay care while searching for a replacement.
No label excerpt provided addresses delaying care/searching for replacement due to expiration.
The expiration date should be checked on the printed expiration date on the outer carton and the container label.
No label excerpt provided includes instructions for checking expiration date(s) on carton/container.
The expiration date should not be based on the date the medication was purchased.
No label excerpt provided includes guidance about purchase date vs expiration date.
If multiple units are available, track dates per device because they may not expire on the same day.
No label excerpt provided includes guidance about tracking multiple units’ expiration.
Proper storage maintains neffy quality up to the printed expiration date.
No label excerpt provided includes storage instructions linked to expiration date.
Neffy should be kept in the conditions stated on the label, including temperature and exposure to moisture/heat.
No label excerpt provided includes storage conditions (temperature/moisture/heat).
Poor storage can shorten usable life even before the printed expiration date.
No label excerpt provided discusses storage effects on shelf life.
Manufacturer guidance on what to do with expired units is in the official prescribing information and patient instructions.
Not supported by the provided excerpts; the claim references label content not shown.
Contradictions
Important Omissions
In the provided response set, no statement was evaluated against the label’s administration instructions about nasal-only use, single use delivering entire dose upon activation, and refraining from sniffing during/after administration (2.2).
Importance:
Moderate
Safety Assessment
Potential Patient Risk:
Moderate
Multiple expiration-related directives are unsupported by the provided label excerpts. If incorrect, such guidance could affect safe use in emergencies.
Regulatory Assessment
| On Label |
No |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
Medium |
Recommendation
Partially Aligned
Primary Issue
Expiration and storage/quality guidance is largely unsupported by the provided prescribing information excerpts, even though several emergency-use aspects are aligned.
Suggested Improvement
Limit claims to what is present in the supplied label excerpts (indication; nasal-only use; single-use; second-dose timing; key cautions). Remove or qualify expiration/storage assertions unless the corresponding FDA label sections or patient instructions are provided.